<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">35219440</PMID><DateCompleted><Year>2022</Year><Month>03</Month><Day>03</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>21</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1558-3147</ISSN><JournalIssue CitedMedium="Internet"><Volume>45</Volume><Issue>1</Issue><PubDate><Year>2022</Year><Month>Mar</Month></PubDate></JournalIssue><Title>The Psychiatric clinics of North America</Title><ISOAbbreviation>Psychiatr Clin North Am</ISOAbbreviation></Journal><ArticleTitle>Emerging Knowledge of the Neurobiology of COVID-19.</ArticleTitle><Pagination><StartPage>29</StartPage><EndPage>43</EndPage><MedlinePgn>29-43</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.psc.2021.11.001</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0193-953X(21)00079-4</ELocationID><Abstract><AbstractText>Many patients with COVID-19 will experience acute or longer-term neuropsychiatric complications. The neurobiological mechanisms behind these are beginning to emerge; however, the neurotropic hypothesis is not strongly supported by clinical data. The inflammatory response to SARS-CoV-2 is likely to be responsible for delirium and other common acute neuropsychiatric manifestations. Vascular abnormalities such as endotheliopathies contribute to stroke and cerebral microbleeds, with their attendant neuropsychiatric sequelae. Longer-term neuropsychiatric syndromes fall into 2 broad categories: neuropsychiatric deficits occurring after severe (hospitalized) COVID-19 and "long COVID," which occurs in many patients with a milder acute COVID-19 illness.</AbstractText><CopyrightInformation>Copyright &#xa9; 2021 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Butler</LastName><ForeName>Matthew</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Institute of Psychiatry, Psychology and Neuroscience, King's College, 16 De Crespigny Park, SE5 8AF London. Electronic address: Matthew.butler@kcl.ac.uk.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cross</LastName><ForeName>Benjamin</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>East Lancashire Hospitals NHS Trust, Casterton Ave, Burnley, BB10 2PQ.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hafeez</LastName><ForeName>Danish</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>School of Medical Sciences, The University of Manchester, Oxford Rd, Manchester, M13 9PL, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lim</LastName><ForeName>Mao Fong</ForeName><Initials>MF</Initials><AffiliationInfo><Affiliation>Cambridge University Hospitals NHS Foundation Trust, Hills Rd, Cambridge, CB2 0QQ, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morrin</LastName><ForeName>Hamilton</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Maidstone &amp; Tunbridge Wells NHS Trust, Tonbridge Rd, Royal Tunbridge Wells, TN2 4QJ, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rengasamy</LastName><ForeName>Emma Rachel</ForeName><Initials>ER</Initials><AffiliationInfo><Affiliation>Cwm Taf Morgannwg University Health Board, Ynysmeurig House, Navigation Park, Abercynon, CF45 4SN, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pollak</LastName><ForeName>Tom</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Institute of Psychiatry, Psychology and Neuroscience, King's College, 16 De Crespigny Park, SE5 8AF London.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nicholson</LastName><ForeName>Timothy R</ForeName><Initials>TR</Initials><AffiliationInfo><Affiliation>Institute of Psychiatry, Psychology and Neuroscience, King's College, 16 De Crespigny Park, SE5 8AF London.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>11</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Psychiatr Clin North Am</MedlineTA><NlmUniqueID>7708110</NlmUniqueID><ISSNLinking>0193-953X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009422" MajorTopicYN="N">Nervous System Diseases</DescriptorName><QualifierName UI="Q000821" MajorTopicYN="Y">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009446" MajorTopicYN="N">Neurobiology</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Delirium</Keyword><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">Neurobiology</Keyword><Keyword MajorTopicYN="N">Neuropsychiatry</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>2</Month><Day>27</Day><Hour>20</Hour><Minute>26</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>2</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>3</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>11</Month><Day>11</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35219440</ArticleId><ArticleId IdType="pmc">PMC8580843</ArticleId><ArticleId IdType="doi">10.1016/j.psc.2021.11.001</ArticleId><ArticleId IdType="pii">S0193-953X(21)00079-4</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Worldometer. COVID-19 CORONAVIRUS PANDEMIC. https://www.worldometers.info/coronavirus/ Available at: Accessed July 22, 2021.</Citation></Reference><Reference><Citation>Butler M., Pollak T.A., Rooney A.G., et al. Neuropsychiatric complications of covid-19. BMJ. 2020:m3871. doi: 10.1136/bmj.m3871.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m3871</ArticleId><ArticleId IdType="pubmed">33051183</ArticleId></ArticleIdList></Reference><Reference><Citation>Rogers J.P., Chesney E., Oliver D., et al. Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic. Lancet Psychiatry. 2020;7(7):611&#x2013;627. doi: 10.1016/S2215-0366(20)30203-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2215-0366(20)30203-0</ArticleId><ArticleId IdType="pmc">PMC7234781</ArticleId><ArticleId IdType="pubmed">32437679</ArticleId></ArticleIdList></Reference><Reference><Citation>Rogers JP, Watson C, Badenoch J, et&#xa0;al. The neurology and neuropsychiatry of COVID-19: a systematic review and meta-analysis of the early literature reveals frequent CNS manifestations and key emerging narratives. Published online February 26, 2021. doi:10.1101/2021.02.24.21252335</Citation><ArticleIdList><ArticleId IdType="pubmed">34083395</ArticleId></ArticleIdList></Reference><Reference><Citation>Mondal R., Ganguly U., Deb S., et al. Meningoencephalitis associated with COVID-19: a systematic review. J&#xa0;Neurovirol. 2021;27(1):12&#x2013;25. doi: 10.1007/s13365-020-00923-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13365-020-00923-3</ArticleId><ArticleId IdType="pmc">PMC7765701</ArticleId><ArticleId IdType="pubmed">33367960</ArticleId></ArticleIdList></Reference><Reference><Citation>Watson C.J., Thomas R.H., Solomon T., et al. COVID-19 and psychosis risk: Real or delusional concern? Neurosci Lett. 2021;741:135491. doi: 10.1016/j.neulet.2020.135491.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2020.135491</ArticleId><ArticleId IdType="pubmed">33220366</ArticleId></ArticleIdList></Reference><Reference><Citation>Kennedy M., Helfand B.K.I., Gou R.Y., et al. Delirium in Older Patients With COVID-19 Presenting to the Emergency Department. JAMA Netw Open. 2020;3(11):e2029540. doi: 10.1001/jamanetworkopen.2020.29540.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2020.29540</ArticleId><ArticleId IdType="pmc">PMC7677760</ArticleId><ArticleId IdType="pubmed">33211114</ArticleId></ArticleIdList></Reference><Reference><Citation>Siow I., Lee K.S., Zhang J.J.Y., et al. Stroke as a Neurological Complication of COVID-19: A Systematic Review and Meta-Analysis of Incidence, Outcomes and Predictors. J&#xa0;Stroke Cerebrovasc Dis. 2021;30(3):105549.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7834121</ArticleId><ArticleId IdType="pubmed">33341565</ArticleId></ArticleIdList></Reference><Reference><Citation>Solomon T. Neurological infection with SARS-CoV-2 &#x2014; the story so far. Nat Rev Neurol. 2021;17(2):65&#x2013;66.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7789883</ArticleId><ArticleId IdType="pubmed">33414554</ArticleId></ArticleIdList></Reference><Reference><Citation>Bourgonje A.R., Abdulle A.E., Timens W., et al. Angiotensin-converting enzyme 2 (ACE2) and the pathophysiology of coronavirus disease 2019. J&#xa0;Pathol. 2020;251(3):228&#x2013;248.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7276767</ArticleId><ArticleId IdType="pubmed">32418199</ArticleId></ArticleIdList></Reference><Reference><Citation>Xydakis M.S., Dehgani-Mobaraki P., Holbrook E.H., et al. Smell and taste dysfunction in patients with COVID-19. Lancet Infect Dis. 2020;20(9):1015&#x2013;1016.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7159875</ArticleId><ArticleId IdType="pubmed">32304629</ArticleId></ArticleIdList></Reference><Reference><Citation>Tiwari S.K., Wang S., Smith D., et al. Revealing Tissue-Specific SARS-CoV-2 Infection and Host Responses using Human Stem Cell-Derived Lung and Cerebral Organoids. Stem Cell Rep. 2021;16(3):437&#x2013;445.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7879814</ArticleId><ArticleId IdType="pubmed">33631122</ArticleId></ArticleIdList></Reference><Reference><Citation>Douaud G., Lee S., Alfaro-Almagro F., et al. Brain Imaging before and after COVID-19 in UK Biobank. Neurology. 2021 doi: 10.1101/2021.06.11.21258690.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.06.11.21258690</ArticleId></ArticleIdList></Reference><Reference><Citation>Sykes D.L., Holdsworth L., Jawad N., et al. Post-COVID-19 Symptom Burden: What is Long-COVID and How Should We Manage It? Lung. 2021 doi: 10.1007/s00408-021-00423-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00408-021-00423-z</ArticleId><ArticleId IdType="pmc">PMC7875681</ArticleId><ArticleId IdType="pubmed">33569660</ArticleId></ArticleIdList></Reference><Reference><Citation>Slooter A.J.C., Otte W.M., Devlin J.W., et al. Updated nomenclature of delirium and acute encephalopathy: statement of ten Societies. Intensive Care Med. 2020;46(5):1020&#x2013;1022.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7210231</ArticleId><ArticleId IdType="pubmed">32055887</ArticleId></ArticleIdList></Reference><Reference><Citation>Inouye S.K., Westendorp R.G.J., Saczynski J.S. Delirium in elderly people. Lancet Lond Engl. 2014;383(9920):911&#x2013;922.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4120864</ArticleId><ArticleId IdType="pubmed">23992774</ArticleId></ArticleIdList></Reference><Reference><Citation>van Gool W.A., van de Beek D., Eikelenboom P. Systemic infection and delirium: when cytokines and acetylcholine collide. Lancet Lond Engl. 2010;375(9716):773&#x2013;775.</Citation><ArticleIdList><ArticleId IdType="pubmed">20189029</ArticleId></ArticleIdList></Reference><Reference><Citation>Pun B.T., Badenes R., Heras La Calle G., et al. Prevalence and risk factors for delirium in critically ill patients with COVID-19 (COVID-D): a multicentre cohort study. Lancet Respir Med. 2021;9(3):239&#x2013;250.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7832119</ArticleId><ArticleId IdType="pubmed">33428871</ArticleId></ArticleIdList></Reference><Reference><Citation>Helms J., Kremer S., Merdji H., et al. Neurologic Features in Severe SARS-CoV-2 Infection. N&#xa0;Engl J Med. 2020;382(23):2268&#x2013;2270.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7179967</ArticleId><ArticleId IdType="pubmed">32294339</ArticleId></ArticleIdList></Reference><Reference><Citation>Mattace-Raso F., Polinder-Bos H., Oosterwijk B., et al. Delirium: A Frequent Manifestation in COVID-19 Older Patients. Clin Interv Aging. 2020;15:2245&#x2013;2247.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7718860</ArticleId><ArticleId IdType="pubmed">33293801</ArticleId></ArticleIdList></Reference><Reference><Citation>Varatharaj A., Thomas N., Ellul M.A., et al.  Neurological and neuropsychiatric complications of COVID-19 in 153 patients: a UK-wide surveillance study. Lancet Psychiatry. 2020 https://www.journals.elsevier.com/the-lancet-psychiatry Avaialble at:</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7316461</ArticleId><ArticleId IdType="pubmed">32593341</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehta P., McAuley D.F., Brown M., et al. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet. 2020;395(10229):1033&#x2013;1034.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7270045</ArticleId><ArticleId IdType="pubmed">32192578</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng X.-W., Lu J., Wu C.-L., et al. Three fatal cases of pandemic 2009 influenza A virus infection in Shenzhen are associated with cytokine storm. Respir Physiol Neurobiol. 2011;175(1):185&#x2013;187.</Citation><ArticleIdList><ArticleId IdType="pubmed">21075220</ArticleId></ArticleIdList></Reference><Reference><Citation>Channappanavar R., Perlman S. Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology. Semin Immunopathol. 2017;39(5):529&#x2013;539.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7079893</ArticleId><ArticleId IdType="pubmed">28466096</ArticleId></ArticleIdList></Reference><Reference><Citation>Sinha P., Matthay M.A., Calfee C.S. Is a &#x201c;Cytokine Storm&#x201d; Relevant to COVID-19? JAMA Intern Med. 2020;180(9):1152.</Citation><ArticleIdList><ArticleId IdType="pubmed">32602883</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghazavi A., Ganji A., Keshavarzian N., et al. Cytokine profile and disease severity in patients with COVID-19. Cytokine. 2021;137:155323.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7524708</ArticleId><ArticleId IdType="pubmed">33045526</ArticleId></ArticleIdList></Reference><Reference><Citation>Del Valle D.M., Kim-Schulze S., Huang H.-H., et al. An inflammatory cytokine signature predicts COVID-19 severity and survival. Nat Med. 2020;26(10):1636&#x2013;1643.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7869028</ArticleId><ArticleId IdType="pubmed">32839624</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang C., Yang Y., DeMars K.M., et al. Genetic Deletion or Pharmacological Inhibition of Cyclooxygenase-2 Reduces Blood-Brain Barrier Damage in Experimental Ischemic Stroke. Front Neurol. 2020;11:887.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7468510</ArticleId><ArticleId IdType="pubmed">32973660</ArticleId></ArticleIdList></Reference><Reference><Citation>Buzhdygan T.P., DeOre B.J., Baldwin-Leclair A., et al. The SARS-CoV-2 spike protein alters barrier function in 2D static and 3D microfluidic in&#xa0;vitro models of the human blood-brain barrier. Biorxiv Prepr Serv Biol. 2020 doi: 10.1101/2020.06.15.150912. 101680187.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.06.15.150912</ArticleId><ArticleId IdType="pmc">PMC7547916</ArticleId><ArticleId IdType="pubmed">33053430</ArticleId></ArticleIdList></Reference><Reference><Citation>Alexopoulos H., Magira E., Bitzogli K., et al. Anti&#x2013;SARS-CoV-2 antibodies in the CSF, blood-brain barrier dysfunction, and neurological outcome: Studies in 8 stuporous and comatose patients. Neurol - Neuroimmunol Neuroinflammation. 2020;7(6):e893.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7577546</ArticleId><ArticleId IdType="pubmed">32978291</ArticleId></ArticleIdList></Reference><Reference><Citation>Matschke J., L&#xfc;tgehetmann M., Hagel C., et al. Neuropathology of patients with COVID-19 in Germany: a post-mortem case series. Lancet Neurol. 2020;19(11):919&#x2013;929.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7535629</ArticleId><ArticleId IdType="pubmed">33031735</ArticleId></ArticleIdList></Reference><Reference><Citation>Cunningham C. Systemic inflammation and delirium: important co-factors in the progression of dementia. Biochem Soc Trans. 2011;39(4):945&#x2013;953.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4157218</ArticleId><ArticleId IdType="pubmed">21787328</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng J., Zhou F., Hou W., et al. The prevalence of depression, anxiety, and sleep disturbances in COVID-19 patients: a meta-analysis. Ann N Y Acad Sci. 2021;1486(1):90&#x2013;111.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7675607</ArticleId><ArticleId IdType="pubmed">33009668</ArticleId></ArticleIdList></Reference><Reference><Citation>Perlis R.H., Ognyanova K., Santillana M., et al. Association of Acute Symptoms of COVID-19 and Symptoms of Depression in Adults. JAMA Netw Open. 2021;4(3):e213223.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7955267</ArticleId><ArticleId IdType="pubmed">33710287</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee C.-H., Giuliani F. The Role of Inflammation in Depression and Fatigue. Front Immunol. 2019;10:1696. doi: 10.3389/fimmu.2019.01696.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2019.01696</ArticleId><ArticleId IdType="pmc">PMC6658985</ArticleId><ArticleId IdType="pubmed">31379879</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller A.H., Raison C.L. The role of inflammation in depression: from evolutionary imperative to modern treatment target. Nat Rev Immunol. 2016;16(1):22&#x2013;34.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5542678</ArticleId><ArticleId IdType="pubmed">26711676</ArticleId></ArticleIdList></Reference><Reference><Citation>Nerurkar L., Siebert S., McInnes I.B., et al. Rheumatoid arthritis and depression: an inflammatory perspective. Lancet Psychiatry. 2019;6(2):164&#x2013;173.</Citation><ArticleIdList><ArticleId IdType="pubmed">30366684</ArticleId></ArticleIdList></Reference><Reference><Citation>Machado M.O., Oriolo G., Bortolato B., et al. Biological mechanisms of depression following treatment with interferon for chronic hepatitis C: A critical systematic review. J&#xa0;Affect Disord. 2017;209:235&#x2013;245.</Citation><ArticleIdList><ArticleId IdType="pubmed">27936453</ArticleId></ArticleIdList></Reference><Reference><Citation>Gennaro M.M., Mariagrazia P., De Lorenzo R., et al. Persistent psychopathology and neurocognitive impairment in COVID-19 survivors: effect of inflammatory biomarkers at three-month follow-up. Brain Behav Immun. 2021 doi: 10.1016/j.bbi.2021.02.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2021.02.021</ArticleId><ArticleId IdType="pmc">PMC7903920</ArticleId><ArticleId IdType="pubmed">33639239</ArticleId></ArticleIdList></Reference><Reference><Citation>Serrano Garc&#xed;a A., Mont&#xe1;nchez Mateo J., Franch Pato C.M., et al. Interleukin 6 and depression in patients affected by Covid-19. Med Cl&#xed;nica Engl Ed. 2021 doi: 10.1016/j.medcle.2020.11.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.medcle.2020.11.013</ArticleId><ArticleId IdType="pmc">PMC7931695</ArticleId><ArticleId IdType="pubmed">33688583</ArticleId></ArticleIdList></Reference><Reference><Citation>Lenzi G.L., Altieri M., Maestrini I. Post-stroke depression. Rev Neurol (Paris) 2008;164(10):837&#x2013;840.</Citation><ArticleIdList><ArticleId IdType="pubmed">18771785</ArticleId></ArticleIdList></Reference><Reference><Citation>Parsons N., Outsikas A., Parish A., et al. Modelling the Anatomic Distribution of Neurologic Events in Patients with COVID-19: A Systematic Review of MRI Findings. AJNR Am J Neuroradiol. 2021 doi: 10.3174/ajnr.A7113.</Citation><ArticleIdList><ArticleId IdType="doi">10.3174/ajnr.A7113</ArticleId><ArticleId IdType="pmc">PMC8324279</ArticleId><ArticleId IdType="pubmed">33888458</ArticleId></ArticleIdList></Reference><Reference><Citation>Herrmann L.L., Le Masurier M., Ebmeier K.P. White matter hyperintensities in late life depression: a systematic review. J&#xa0;Neurol Neurosurg Psychiatry. 2007;79(6):619&#x2013;624.</Citation><ArticleIdList><ArticleId IdType="pubmed">17717021</ArticleId></ArticleIdList></Reference><Reference><Citation>The WHO Rapid Evidence Appraisal for COVID-19. Therapies (REACT) Working Group. Sterne J.A.C., Murthy S., et al. Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19: A Meta-analysis. JAMA. 2020;324(13):1330.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7489434</ArticleId><ArticleId IdType="pubmed">32876694</ArticleId></ArticleIdList></Reference><Reference><Citation>Dubovsky A.N., Arvikar S., Stern T.A., et al. The Neuropsychiatric Complications of Glucocorticoid Use: Steroid Psychosis Revisited. Psychosomatics. 2012;53(2):103&#x2013;115.</Citation><ArticleIdList><ArticleId IdType="pubmed">22424158</ArticleId></ArticleIdList></Reference><Reference><Citation>Pariante C.M., Lightman S.L. The HPA axis in major depression: classical theories and new developments. Trends Neurosci. 2008;31(9):464&#x2013;468.</Citation><ArticleIdList><ArticleId IdType="pubmed">18675469</ArticleId></ArticleIdList></Reference><Reference><Citation>Datson N.A., Morsink M.C., Meijer O.C., et al. Central corticosteroid actions: Search for gene targets. Eur J Pharmacol. 2008;583(2&#x2013;3):272&#x2013;289.</Citation><ArticleIdList><ArticleId IdType="pubmed">18295201</ArticleId></ArticleIdList></Reference><Reference><Citation>Iqbal Y., Al Abdulla M.A., Albrahim S., et al. Psychiatric presentation of patients with acute SARS-CoV-2 infection: a retrospective review of 50 consecutive patients seen by a consultation-liaison psychiatry team. BJPsych Open. 2020;6(5):e109.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7484218</ArticleId><ArticleId IdType="pubmed">32907692</ArticleId></ArticleIdList></Reference><Reference><Citation>Butler M., Delvi A., Mujic F., et al. Reduced Activity in an Inpatient Liaison Psychiatry Service During the First Wave of the COVID-19 Pandemic: Comparison With 2019 Data and Characterization of the SARS-CoV-2 Positive Cohort. Front Psychiatry. 2021;12:619550.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7884445</ArticleId><ArticleId IdType="pubmed">33603687</ArticleId></ArticleIdList></Reference><Reference><Citation>K&#x119;pi&#x144;ska A.P., Iyegbe C.O., Vernon A.C., et al. Schizophrenia and Influenza at the Centenary of the 1918-1919 Spanish Influenza Pandemic: Mechanisms of Psychosis Risk. Front Psychiatry. 2020;11:72.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7054463</ArticleId><ArticleId IdType="pubmed">32174851</ArticleId></ArticleIdList></Reference><Reference><Citation>Yolken R.H., Torrey E.F. Are some cases of psychosis caused by microbial agents? A review of the evidence. Mol Psychiatry. 2008;13(5):470&#x2013;479.</Citation><ArticleIdList><ArticleId IdType="pubmed">18268502</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M., Geddes J.R., Husain M., et al. 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records. Lancet Psychiatry. 2021;8(5):416&#x2013;427.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8023694</ArticleId><ArticleId IdType="pubmed">33836148</ArticleId></ArticleIdList></Reference><Reference><Citation>Najjar S., Steiner J., Najjar A., et al. A&#xa0;clinical approach to new-onset psychosis associated with immune dysregulation: the concept of autoimmune psychosis. J&#xa0;Neuroinflammation. 2018;15(1):40.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5809809</ArticleId><ArticleId IdType="pubmed">29433523</ArticleId></ArticleIdList></Reference><Reference><Citation>Khandaker G.M., Zimbron J., Dalman C., et al. Childhood infection and adult schizophrenia: A meta-analysis of population-based studies. Schizophr Res. 2012;139(1&#x2013;3):161&#x2013;168.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3485564</ArticleId><ArticleId IdType="pubmed">22704639</ArticleId></ArticleIdList></Reference><Reference><Citation>Khandaker G.M., Zimbron J., Lewis G., et al. Prenatal maternal infection, neurodevelopment and adult schizophrenia: a systematic review of population-based studies. Psychol Med. 2013;43(2):239&#x2013;257.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3479084</ArticleId><ArticleId IdType="pubmed">22717193</ArticleId></ArticleIdList></Reference><Reference><Citation>Pollak T.A., Lennox B.R., M&#xfc;ller S., et al. Autoimmune psychosis: an international consensus on an approach to the diagnosis and management of psychosis of suspected autoimmune origin. Lancet Psychiatry. 2020;7(1):93&#x2013;108.</Citation><ArticleIdList><ArticleId IdType="pubmed">31669058</ArticleId></ArticleIdList></Reference><Reference><Citation>Ellul M.A., Benjamin L., Singh B., et al. Neurological associations of COVID-19. Lancet Neurol. 2020;19(9):767&#x2013;783.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7332267</ArticleId><ArticleId IdType="pubmed">32622375</ArticleId></ArticleIdList></Reference><Reference><Citation>McCuddy M., Kelkar P., Zhao Y., et al. Acute Demyelinating Encephalomyelitis (ADEM) in COVID-19 Infection: A Case Series. Neurology. 2020 doi: 10.1101/2020.07.15.20126730.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.07.15.20126730</ArticleId><ArticleId IdType="pubmed">33109874</ArticleId></ArticleIdList></Reference><Reference><Citation>Pilotto A., Masciocchi S., Volonghi I., et al. Clinical Presentation and Outcomes of Severe Acute Respiratory Syndrome Coronavirus 2&#x2013;Related Encephalitis: The ENCOVID Multicenter Study. J&#xa0;Infect Dis. 2021;223(1):28&#x2013;37.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7543535</ArticleId><ArticleId IdType="pubmed">32986824</ArticleId></ArticleIdList></Reference><Reference><Citation>Franke C., Ferse C., Kreye J., et al. High frequency of cerebrospinal fluid autoantibodies in COVID-19 patients with neurological symptoms. Brain Behav Immun. 2021;93:415&#x2013;419.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7834471</ArticleId><ArticleId IdType="pubmed">33359380</ArticleId></ArticleIdList></Reference><Reference><Citation>Kreye J., Reincke S.M., Pr&#xfc;ss H. Do cross-reactive antibodies cause neuropathology in COVID-19? Nat Rev Immunol. 2020;20(11):645&#x2013;646.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7537977</ArticleId><ArticleId IdType="pubmed">33024283</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao A., Rohaut B., Le Guennec L., et al. Severe COVID-19-related encephalitis can respond to immunotherapy. Brain. 2020;2 doi: 10.1093/brain/awaa337. awaa337.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awaa337</ArticleId><ArticleId IdType="pmc">PMC7665364</ArticleId><ArticleId IdType="pubmed">33064794</ArticleId></ArticleIdList></Reference><Reference><Citation>Vogrig A., Gigli G.L., Bn&#xe0; C., et al. Stroke in patients with COVID-19: Clinical and neuroimaging characteristics. Neurosci Lett. 2021;743:135564.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7749733</ArticleId><ArticleId IdType="pubmed">33352277</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferro J.M., Caeiro L., Figueira M.L. Neuropsychiatric sequelae of stroke. Nat Rev Neurol. 2016;12(5):269&#x2013;280.</Citation><ArticleIdList><ArticleId IdType="pubmed">27063107</ArticleId></ArticleIdList></Reference><Reference><Citation>Jensen-Kondering U., Neumann A., Margraf N.G., et al. Cerebral Imaging in Patients with COVID-19 and Neurological Symptoms: First Experience from two University Hospitals in Northern Germany. ROFO Fortschr Geb Rontgenstr Nuklearmed. 2020 doi: 10.1055/a-1265-7209.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/a-1265-7209</ArticleId><ArticleId IdType="pubmed">33212537</ArticleId></ArticleIdList></Reference><Reference><Citation>Edlow B.L., Takahashi E., Wu O., et al. Neuroanatomic connectivity of the human ascending arousal system critical to consciousness and its disorders. J&#xa0;Neuropathol Exp Neurol. 2012;71(6):531&#x2013;546.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3387430</ArticleId><ArticleId IdType="pubmed">22592840</ArticleId></ArticleIdList></Reference><Reference><Citation>Kremer S., Lersy F., Anheim M., et al. Neurologic and neuroimaging findings in patients with COVID-19: A retrospective multicenter study. Neurology. 2020;95(13):e1868&#x2013;e1882.</Citation><ArticleIdList><ArticleId IdType="pubmed">32680942</ArticleId></ArticleIdList></Reference><Reference><Citation>Goshua G., Pine A.B., Meizlish M.L., et al. Endotheliopathy in COVID-19-associated coagulopathy: evidence from a single-centre, cross-sectional study. Lancet Haematol. 2020;7(8):e575&#x2013;e582.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7326446</ArticleId><ArticleId IdType="pubmed">32619411</ArticleId></ArticleIdList></Reference><Reference><Citation>Meinhardt J., Radke J., Dittmayer C., et al. Olfactory transmucosal SARS-CoV-2 invasion as a port of central nervous system entry in individuals with COVID-19. Nat Neurosci. 2021;24(2):168&#x2013;175.</Citation><ArticleIdList><ArticleId IdType="pubmed">33257876</ArticleId></ArticleIdList></Reference><Reference><Citation>Mukerji S.S., Solomon I.H. What can we learn from brain autopsies in COVID-19? Neurosci Lett. 2021;742:135528.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7687409</ArticleId><ArticleId IdType="pubmed">33248159</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee M.-H., Perl D.P., Nair G., et al. Microvascular Injury in the Brains of Patients with Covid-19. N&#xa0;Engl J Med. 2021;384(5):481&#x2013;483.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7787217</ArticleId><ArticleId IdType="pubmed">33378608</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith M., Meyfroidt G. Critical illness: the brain is always in the line of fire. Intensive Care Med. 2017;43(6):870&#x2013;873.</Citation><ArticleIdList><ArticleId IdType="pubmed">28386728</ArticleId></ArticleIdList></Reference><Reference><Citation>Baker H.A., Safavynia S.A., Evered L.A. The &#x2018;third wave&#x2019;: impending cognitive and functional decline in COVID-19 survivors. Br J Anaesth. 2021;126(1):44&#x2013;47.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7577658</ArticleId><ArticleId IdType="pubmed">33187638</ArticleId></ArticleIdList></Reference><Reference><Citation>Conklin J., Frosch M.P., Mukerji S.S., et al. Susceptibility-weighted imaging reveals cerebral microvascular injury in severe COVID-19. J&#xa0;Neurol Sci. 2021;421:117308.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7832284</ArticleId><ArticleId IdType="pubmed">33497950</ArticleId></ArticleIdList></Reference><Reference><Citation>Fanou E.M., Coutinho J.M., Shannon P., et al. Critical Illness-Associated Cerebral Microbleeds. Stroke. 2017;48(4):1085&#x2013;1087.</Citation><ArticleIdList><ArticleId IdType="pubmed">28235962</ArticleId></ArticleIdList></Reference><Reference><Citation>Werring D.J., Frazer D.W., Coward L.J., et al. Cognitive dysfunction in patients with cerebral microbleeds on T2&#x2217;-weighted gradient-echo MRI. Brain J Neurol. 2004;127(Pt 10):2265&#x2013;2275.</Citation><ArticleIdList><ArticleId IdType="pubmed">15282216</ArticleId></ArticleIdList></Reference><Reference><Citation>Badenoch J.B., Rengasamy E.R., Watson C.J., et al. Persistent Neuropsychiatric Symptoms after COVID-19: A Systematic Review and Meta-Analysis. Psychiatry Clin Psychol. 2021 doi: 10.1101/2021.04.30.21256413.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.04.30.21256413</ArticleId><ArticleId IdType="pmc">PMC8833580</ArticleId><ArticleId IdType="pubmed">35169700</ArticleId></ArticleIdList></Reference><Reference><Citation>Ladds E., Rushforth A., Wieringa S., et al. Persistent symptoms after Covid-19: qualitative study of 114 &#x201c;long Covid&#x201d; patients and draft quality principles for services. BMC Health Serv Res. 2020;20(1):1144.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7750006</ArticleId><ArticleId IdType="pubmed">33342437</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis H.E., Assaf G.S., McCorkell L., et al. Characterizing long COVID in an international cohort: 7&#xa0;months of symptoms and their impact. Eclinicalmedicine. 2021:101019. doi: 10.1016/j.eclinm.2021.101019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.101019</ArticleId><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A., Sehgal K., Gupta A., et al. Post-acute COVID-19 syndrome. Nat Med. 2021;27(4):601&#x2013;615.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Taboada M., Cari&#xf1;ena A., Moreno E., et al. Post-COVID-19 functional status six-months after hospitalization. J&#xa0;Infect. 2021;82(4):e31&#x2013;e33.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7834022</ArticleId><ArticleId IdType="pubmed">33373650</ArticleId></ArticleIdList></Reference><Reference><Citation>Myers E.A., Smith D.A., Allen S.R., et al. Post-ICU syndrome: Rescuing the undiagnosed. J&#xa0;Am Acad Physician Assist. 2016;29(4):34&#x2013;37.</Citation><ArticleIdList><ArticleId IdType="pubmed">27023654</ArticleId></ArticleIdList></Reference><Reference><Citation>Garc&#xed;a-Abell&#xe1;n J., Padilla S., Fern&#xe1;ndez-Gonz&#xe1;lez M., et al. Antibody Response to SARS-CoV-2 is Associated with Long-term Clinical Outcome in Patients with COVID-19: a Longitudinal Study. J&#xa0;Clin Immunol. 2021 doi: 10.1007/s10875-021-01083-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10875-021-01083-7</ArticleId><ArticleId IdType="pmc">PMC8285689</ArticleId><ArticleId IdType="pubmed">34273064</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandal S., Barnett J., Brill S.E., et al. &#x2018;Long-COVID&#x2019;: a cross-sectional study of persisting symptoms, biomarker and imaging abnormalities following hospitalisation for COVID-19. Thorax. 2021;76(4):396&#x2013;398.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7615158</ArticleId><ArticleId IdType="pubmed">33172844</ArticleId></ArticleIdList></Reference><Reference><Citation>Doykov I., H&#xe4;llqvist J., Gilmour K.C., et al. &#x2018;The long tail of Covid-19&#x2019; - The detection of a prolonged inflammatory response after a SARS-CoV-2 infection in asymptomatic and mildly affected patients. F1000Research. 2021;9:1349.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7745182</ArticleId><ArticleId IdType="pubmed">33391730</ArticleId></ArticleIdList></Reference><Reference><Citation>Phetsouphanh C., Darley D., Howe A., et al. Infectious Diseases (except HIV/AIDS); 2021. Immunological dysfunction persists for 8 Months following initial mild-moderate SARS-CoV-2 infection.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.06.01.21257759</ArticleId><ArticleId IdType="pubmed">35027728</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng S., Fan J., Yu F., et al. Viral load dynamics and disease severity in patients infected with SARS-CoV-2 in Zhejiang province, China, January-March 2020: retrospective cohort study. BMJ. 2020:m1443. doi: 10.1136/bmj.m1443.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m1443</ArticleId><ArticleId IdType="pmc">PMC7190077</ArticleId><ArticleId IdType="pubmed">32317267</ArticleId></ArticleIdList></Reference><Reference><Citation>Altmann D.M., Boyton R.J. Decoding the unknowns in long covid. BMJ. 2021;4:n132. doi: 10.1136/bmj.n132.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n132</ArticleId><ArticleId IdType="pubmed">33541867</ArticleId></ArticleIdList></Reference><Reference><Citation>Dani M., Dirksen A., Taraborrelli P., et al. Autonomic dysfunction in &#x2018;long COVID&#x2019;: rationale, physiology and management strategies. Clin Med. 2021;21(1):e63&#x2013;e67.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7850225</ArticleId><ArticleId IdType="pubmed">33243837</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrucci R., Dini M., Groppo E., et al. Long-Lasting Cognitive Abnormalities after COVID-19. Brain Sci. 2021;11(2):235.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7917789</ArticleId><ArticleId IdType="pubmed">33668456</ArticleId></ArticleIdList></Reference><Reference><Citation>Colbenson G.A., Johnson A., Wilson M.E. Post-intensive care syndrome: impact, prevention, and management. Breathe. 2019;15(2):98&#x2013;101.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6544795</ArticleId><ArticleId IdType="pubmed">31191717</ArticleId></ArticleIdList></Reference><Reference><Citation>Del Brutto O.H., Wu S., Mera R.M., et al. Cognitive decline among individuals with history of mild symptomatic SARS-CoV-2 infection: A longitudinal prospective study nested to a population cohort. Eur J Neurol. 2021 doi: 10.1111/ene.14775.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.14775</ArticleId><ArticleId IdType="pmc">PMC8014083</ArticleId><ArticleId IdType="pubmed">33576150</ArticleId></ArticleIdList></Reference><Reference><Citation>Alemanno F., Houdayer E., Parma A., et al. COVID-19 cognitive deficits after respiratory assistance in the subacute phase: a COVID-rehabilitation unit experience. PLoS One. 2021;16(2):e0246590.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7870071</ArticleId><ArticleId IdType="pubmed">33556127</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Keeffe S., Lavan J. The Prognostic Significance of Delirium in Older Hospital Patients. J&#xa0;Am Geriatr Soc. 1997;45(2):174&#x2013;178.</Citation><ArticleIdList><ArticleId IdType="pubmed">9033515</ArticleId></ArticleIdList></Reference><Reference><Citation>Hossmann K.A. The hypoxic brain. Insights from ischemia research. Adv Exp Med Biol. 1999;474:155&#x2013;169.</Citation><ArticleIdList><ArticleId IdType="pubmed">10635000</ArticleId></ArticleIdList></Reference><Reference><Citation>Qin Y., Wu J., Chen T., et al. Long-term micro-structure and cerebral blood flow changes in patients recovered from COVID-19 without neurological manifestations. J&#xa0;Clin Invest. 2021;25 doi: 10.1172/JCI147329.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI147329</ArticleId><ArticleId IdType="pmc">PMC8262559</ArticleId><ArticleId IdType="pubmed">33630760</ArticleId></ArticleIdList></Reference><Reference><Citation>Guedj E., Campion J.Y., Dudouet P., et al. 18F-FDG brain PET hypometabolism in patients with long COVID. Eur J Nucl Med Mol Imaging. 2021;26 doi: 10.1007/s00259-021-05215-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00259-021-05215-4</ArticleId><ArticleId IdType="pmc">PMC7837643</ArticleId><ArticleId IdType="pubmed">33501506</ArticleId></ArticleIdList></Reference><Reference><Citation>Boldrini M., Canoll P.D., Klein R.S. How COVID-19 Affects the Brain. JAMA Psychiatry. 2021 doi: 10.1001/jamapsychiatry.2021.0500.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamapsychiatry.2021.0500</ArticleId><ArticleId IdType="pmc">PMC9894299</ArticleId><ArticleId IdType="pubmed">33769431</ArticleId></ArticleIdList></Reference><Reference><Citation>McWhirter L., Ritchie C., Stone J., et al. Functional cognitive disorders: a systematic review. Lancet Psychiatry. 2020 doi: 10.1016/S2215-0366(19)30405-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2215-0366(19)30405-5</ArticleId><ArticleId IdType="pubmed">31732482</ArticleId></ArticleIdList></Reference><Reference><Citation>Teodoro T., Edwards M.J., Isaacs J.D. A&#xa0;unifying theory for cognitive abnormalities in functional neurological disorders, fibromyalgia and chronic fatigue syndrome: systematic review. J&#xa0;Neurol Neurosurg Psychiatry. 2018;89(12):1308&#x2013;1319.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6288708</ArticleId><ArticleId IdType="pubmed">29735513</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith V., Seo D., Warty R., et al. Maternal and neonatal outcomes associated with COVID-19 infection: A systematic review. PLoS One. 2020;15(6):e0234187.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7272020</ArticleId><ArticleId IdType="pubmed">32497090</ArticleId></ArticleIdList></Reference><Reference><Citation>Cavalcante M.B., de Melo Bezerra Cavalcante C.T., Sarno M., et al. Maternal immune responses and obstetrical outcomes of pregnant women with COVID-19 and possible health risks of offspring. J&#xa0;Reprod Immunol. 2021;143:103250. doi: 10.1016/j.jri.2020.103250.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jri.2020.103250</ArticleId><ArticleId IdType="pmc">PMC7676367</ArticleId><ArticleId IdType="pubmed">33249335</ArticleId></ArticleIdList></Reference><Reference><Citation>Zimmer A., Youngblood A., Adnane A., et al. Prenatal exposure to viral infection and neuropsychiatric disorders in offspring: A review of the literature and recommendations for the COVID-19 pandemic. Brain Behav Immun. 2021;91:756&#x2013;770.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7759331</ArticleId><ArticleId IdType="pubmed">33152446</ArticleId></ArticleIdList></Reference><Reference><Citation>Atlad&#xf3;ttir H.&#xd3;., Thorsen P., &#xd8;stergaard L., et al. Maternal Infection Requiring Hospitalization During Pregnancy and Autism Spectrum Disorders. J&#xa0;Autism Dev Disord. 2010;40(12):1423&#x2013;1430.</Citation><ArticleIdList><ArticleId IdType="pubmed">20414802</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown A.S. Nonaffective Psychosis After Prenatal Exposure to Rubella. Am J Psychiatry. 2000;157(3):438&#x2013;443.</Citation><ArticleIdList><ArticleId IdType="pubmed">10698821</ArticleId></ArticleIdList></Reference><Reference><Citation>Buka S.L. Maternal Infections and Subsequent Psychosis Among Offspring. Arch Gen Psychiatry. 2001;58(11):1032&#x2013;1037.</Citation><ArticleIdList><ArticleId IdType="pubmed">11695949</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi G.B., Yim Y.S., Wong H., et al. The maternal interleukin-17a pathway in mice promotes autism-like phenotypes in offspring. Science. 2016;351(6276):933&#x2013;939.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4782964</ArticleId><ArticleId IdType="pubmed">26822608</ArticleId></ArticleIdList></Reference><Reference><Citation>Khashan A.S., Abel K.M., McNamee R., et al. Higher Risk of Offspring Schizophrenia Following Antenatal Maternal Exposure to Severe Adverse Life Events. Arch Gen Psychiatry. 2008;65(2):146.</Citation><ArticleIdList><ArticleId IdType="pubmed">18250252</ArticleId></ArticleIdList></Reference><Reference><Citation>Barisic A. Conceived in the covid-19 crisis: impact of maternal stress and anxiety on fetal neurobehavioral development. J&#xa0;Psychosom Obstet Gynaecol. 2020;(bu1, 8308648):1. doi: 10.1080/0167482X.2020.1755838.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/0167482X.2020.1755838</ArticleId><ArticleId IdType="pubmed">32326793</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>